SCHEMBL20344333

SCHEMBL20344333

CO[C@H]1CC[C@H](NC(=O)c2c(NC(=O)C3CCCCC3C(=O)O)sc3c2CCC3)CC1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.65
RAB9A P51151 1/20 0.65
MAPT P10636 3/20 0.61
HTT P42858 1/20 0.61
REV1 Q9UBZ9 1/20 0.53
CNR2 P34972 2/20 0.50
CNR1 P21554 1/20 0.50
POLB P06746 1/20 0.50
CHD1L Q86WJ1 1/20 0.50
PARP9 Q8IXQ6 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
FABP4 P15090 8/20 0.48
FABP5 Q01469 8/20 0.48
KDM4E B2RXH2 4/20 0.48
HSD17B10 Q99714 3/20 0.48
HPGD P15428 2/20 0.48
TSHR P16473 1/20 0.48
MAPK1 P28482 1/20 0.47
RXFP1 Q9HBX9 1/20 0.47
ALOX15 P16050 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20353887 1.00 ALDH1A1 (0.65) ALDH1A1RAB9AMAPTHTTREV1
SCHEMBL24598779 0.89 ALDH1A1 (0.62) ALDH1A1RAB9AMAPTHTTREV1
SCHEMBL20340298 0.89 ALDH1A1 (0.62) ALDH1A1RAB9AMAPTHTTREV1
SCHEMBL20353999 0.89 ALDH1A1 (0.62) ALDH1A1RAB9AMAPTHTTREV1
SCHEMBL20339092 0.89 ALDH1A1 (0.67) ALDH1A1RAB9AMAPTHTTREV1
SCHEMBL21577820 0.84 ALDH1A1 (0.59) ALDH1A1RAB9AMAPTHTTREV1
SCHEMBL20353886 0.82 ALDH1A1 (0.64) ALDH1A1MAPTREV1CNR2CNR1
SCHEMBL24598834 0.81 ALDH1A1 (0.61) ALDH1A1RAB9AMAPTHTTCNR2
SCHEMBL24426732 0.80 ALDH1A1 (0.73) ALDH1A1RAB9AMAPTHTTPOLB
SCHEMBL24426767 0.79 ALDH1A1 (0.60) ALDH1A1RAB9AMAPTHTTREV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11807618-B2 Thiophene derivatives as antiviral agents ENYO PHARMA (FR) 2023-11-07 US claimed
US-20220213053-A1 THIOPHENE DERIVATIVES AS ANTIVIRAL AGENTS ENYO PHARMA (FR) 2022-07-07 US claimed
EP-3562818-B1 THIOPHENE DERIVATIVES AS ANTIVIRAL AGENTS ENYO PHARMA (FR) 2022-05-18 EP claimed
US-20190352275-A1 THIOPHENE DERIVATIVES AS ANTIVIRAL AGENTS ENYO PHARMA (FR) 2019-11-21 US claimed
EP-3562818-A1 THIOPHENE DERIVATIVES AS ANTIVIRAL AGENTS Enyo Pharma (FR) 2019-11-06 EP claimed
WO-2018122317-A1 THIOPHENE DERIVATIVES AS ANTIVIRAL AGENTS ENYO PHARMA (FR) 2018-07-05 WO claimed
US-11807618-B2 Thiophene derivatives as antiviral agents ENYO PHARMA (FR) 2023-11-07 US disclosed
US-11807618-B2 Thiophene derivatives as antiviral agents ENYO PHARMA (FR) 2023-11-07 US disclosed
US-20220213053-A1 THIOPHENE DERIVATIVES AS ANTIVIRAL AGENTS ENYO PHARMA (FR) 2022-07-07 US disclosed
EP-3562818-B1 THIOPHENE DERIVATIVES AS ANTIVIRAL AGENTS ENYO PHARMA (FR) 2022-05-18 EP disclosed
EP-3562818-B1 THIOPHENE DERIVATIVES AS ANTIVIRAL AGENTS ENYO PHARMA (FR) 2022-05-18 EP disclosed
US-11279683-B2 Thiophene derivatives as antiviral agents ENYO PHARMA (FR) 2022-03-22 US disclosed
US-11279683-B2 Thiophene derivatives as antiviral agents ENYO PHARMA (FR) 2022-03-22 US disclosed
US-20190352275-A1 THIOPHENE DERIVATIVES AS ANTIVIRAL AGENTS ENYO PHARMA (FR) 2019-11-21 US disclosed
US-20190352275-A1 THIOPHENE DERIVATIVES AS ANTIVIRAL AGENTS ENYO PHARMA (FR) 2019-11-21 US disclosed
EP-3562818-A1 THIOPHENE DERIVATIVES AS ANTIVIRAL AGENTS Enyo Pharma (FR) 2019-11-06 EP disclosed
WO-2018122317-A1 THIOPHENE DERIVATIVES AS ANTIVIRAL AGENTS ENYO PHARMA (FR) 2018-07-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220213053-A1 THIOPHENE DERIVATIVES AS ANTIVIRAL AGENTS MAVS, EIF2AK2, IRF3 ALDH1A1 3437/4885RAB9A 1661/4885MAPT 3934/4885
US-11279683-B2 Thiophene derivatives as antiviral agents MAVS, EIF2AK2, IRF3 ALDH1A1 1759/4885RAB9A 1653/4885MAPT 4150/4885
US-20190352275-A1 THIOPHENE DERIVATIVES AS ANTIVIRAL AGENTS MAVS, EIF2AK2, IRF3 ALDH1A1 1759/4885RAB9A 1653/4885MAPT 4150/4885
US-11807618-B2 Thiophene derivatives as antiviral agents MAVS, EIF2AK2, IRF3 ALDH1A1 3437/4885RAB9A 1661/4885MAPT 3934/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.